Scientific Wave Pushes CBER Into Brighter Light

 
• By Nancy Bradish Myers

What are US regulators doing to prepare for adequate review of the upcoming wave of gene therapy applications, and what other actions could CBER take to ensure it is able to facilitate the expected onslaught of breakthroughs in this field? Consultant Nancy Bradish Myers weighs in.  

rough colored ocean wave falling down at sunset time
The over 900 active investigational new drug applications in the US are proof the gene therapy wave continues to gather strength and speed. • Source: Shutterstock

More from US FDA

More from Agency Leadership